Bora manufactures more than 20 commercial products for GSK at its Mississauga facility, supporting infectious disease, mental health, dermatology, & other critical therapeutic areas GSK is the largest ...
With a productive working relationship between the two companies already well established, Bora Pharmaceuticals is renewing a $250 million global manufacturing agreement with British drugmaker GSK. | ...
Bora Pharmaceuticals extended its expansion tear by taking a 30.5% stake in fellow Taiwanese drugmaker Tanvex BioPharma, boosting the CDMO’s biomanufacturing capabilities. The deal, which is expected ...
Bora Pharmaceuticals and GSK are renewing a five-year manufacturing partnership with the signing of a new strategic agreement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results